Dr Iñaki Sanz will give a conference on the 26 January

20 de January de 2017

The next 26th of January will take place the first conference of the Programme Santander Biomedical Lectures that is organized by IDIVAL, University of Cantabria and IBBTEC. The conference will be given by Iñaki Sanz, Chief of the Division of Rheumatology at Emory Clinic (Atlanta) under the title:

“Bases inmunológicas y epigenéticas de activación de linfocitos B y células plasmáticas en el LES. Implicaciones diagnósticas y terapéuticas”.

Dr. Sanz, has recently been named Distinguished Student at the University of Cantabria, is one of the world's leading researchers in B-cell research and autoimmune diseases.

Dr. Sanz was Chief of the Division of Immunology and Rheumatology at the University of Rochester since 1996 until his move to Emory in April of 2012 as the Mason Lowance Professor of Medicine and Pediatrics, Chief of the Division of Rheumatology, Director of the Lowance Center for Human Immunology and Georgia Research Alliance Distinguished Scholar in Human Immunology.

Dr. Sanz has extensive expertise in the study of human autoantibodies and B-cells. He has performed pioneering studies of B-cell depletion in human SLE. In the process, his lab has developed great expertise in the multi-chromatic FCM analysis of human B-cells, generation of monoclonal antibodies from single cells and more recently, next generation sequencing.

For the last 11 years, Dr. Sanz has been the director of one of only 8 NIH-funded Autoimmunity Centers of Excellence in the nation as well as the Director of the University of Rochester Program for Biodefense of Immunocompromised Populations from 2006-2011. He is also the Principal Investigator of a large multi-institutional Program Project investigating B cells in Health and Disease and was the Director of the Rochester Center for Translational Immunology and Infectious Diseases from 2009-2012. He was a member of the NIAID Allergy and Immunology Study section and has also participated in multiple special review panels and ad-hoc reviews.

The conference will be open to general public and it will take place at the Marques de Valdecilla University Hospital, Salon Tellez (Pavilion 16) at 8.15am. 

By fostering a discussion forum on the current advances in biomedicine, Dr. Sanz will be in Santander throughout the day of the session, to exchange experiences with members of the scientific and clinical community, and to visit the Research centers of our community to talk with all the interested scientifics. 

Those professionals who would like to meet with Dr. Sanz during his stay they can contact with